Search research articles
Contact Us
Filters
Showing results (131-140 of 392) with videos related to
Page
of 40
Sort By:
Plant Disease
|
February 1, 2019
Use of PCR-RFLP Analysis to Monitor Fungicide Resistance in Cercospora beticola Populations from Sugarbeet (Beta vulgaris) in Michigan, United States
N Rosenzweig, L E Hanson, G Clark, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
Christian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.
Oncotarget
|
September 17, 2017
Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation
Nadine Gehrke, Marcus A Wörns, Amrit Mann, et al.
Scientific Reports
|
June 6, 2023
Metabolic dysfunction-associated fatty liver disease in people living with HIV
Maurice Michel, Christian Labenz, Angelo Armandi, et al.
Journal of Cardiovascular Pharmacology
|
April 18, 2007
In vivo cardiac electrophysiologic and antiarrhythmic effects of an isoquinoline IKur blocker, ISQ-1, in rat, dog, and nonhuman primate
Christopher P Regan, Gary L Stump, Audrey A Wallace, et al.
Journal of Lipid Research
|
November 13, 2016
Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study
Marcin Krawczyk, Monika Rau, Jörn M Schattenberg, et al.
Hepatology Communications
|
December 2, 2024
Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice
Nadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
Plos One
|
June 16, 2022
Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-Registry
Monika Rau, Peter Buggisch, Stefan Mauss, et al.
Journal of Hepatology
|
January 26, 2018
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation
Nadine Gehrke, Nadine Hövelmeyer, Ari Waisman, et al.
JHEP Reports : Innovation in Hepatology
|
September 22, 2025
Proteomic signatures reflect effects of semaglutide treatment for MASH
Jörn M Schattenberg, Henning Grønbæk, Iris Kliers, et al.
Page
of 40
Search research articles
Search
Showing results (131-140 of 392) with videos related to
Sort By:
Page
of 40
Plant Disease
|
February 1, 2019
Use of PCR-RFLP Analysis to Monitor Fungicide Resistance in Cercospora beticola Populations from Sugarbeet (Beta vulgaris) in Michigan, United States
N Rosenzweig, L E Hanson, G Clark, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
Christian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.
Oncotarget
|
September 17, 2017
Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation
Nadine Gehrke, Marcus A Wörns, Amrit Mann, et al.
Scientific Reports
|
June 6, 2023
Metabolic dysfunction-associated fatty liver disease in people living with HIV
Maurice Michel, Christian Labenz, Angelo Armandi, et al.
Journal of Cardiovascular Pharmacology
|
April 18, 2007
In vivo cardiac electrophysiologic and antiarrhythmic effects of an isoquinoline IKur blocker, ISQ-1, in rat, dog, and nonhuman primate
Christopher P Regan, Gary L Stump, Audrey A Wallace, et al.
Journal of Lipid Research
|
November 13, 2016
Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study
Marcin Krawczyk, Monika Rau, Jörn M Schattenberg, et al.
Hepatology Communications
|
December 2, 2024
Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice
Nadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
Plos One
|
June 16, 2022
Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-Registry
Monika Rau, Peter Buggisch, Stefan Mauss, et al.
Journal of Hepatology
|
January 26, 2018
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation
Nadine Gehrke, Nadine Hövelmeyer, Ari Waisman, et al.
JHEP Reports : Innovation in Hepatology
|
September 22, 2025
Proteomic signatures reflect effects of semaglutide treatment for MASH
Jörn M Schattenberg, Henning Grønbæk, Iris Kliers, et al.
Page
of 40